Jeffrey Wallin, Gilead Sciences Inc.
Gilead Sciences Inc.Jeffrey Wallin, PhD, is currently a Sr. Director at Gilead Sciences, Inc. in Foster City, California. As a trained immunologist, he has worked primarily in the areas of immuno-oncology and infectious disease. He currently leads a biomarker team at Gilead that studies host responses to HIV and HBV.
Presenter Of 1 Presentation
Oral abstract session
OAB0205 - Vesatolimod, a toll-like receptor 7 (TLR7) agonist, induces dose-dependent immune responses in HIV controllers
Session Name
Room
Abstract Sessions On-Demand Channel
Presenter Of 1 Presentation
Oral abstract session
Vesatolimod, a toll-like receptor 7 (TLR7) agonist, induces dose-dependent immune responses in HIV controllers
Session Name
Room
Abstract Sessions On-Demand Channel
Presenter Of 1 Presentation
Oral abstract session
Vesatolimod, a toll-like receptor 7 (TLR7) agonist, induces dose-dependent immune responses in HIV controllers
Session Name
Room
Abstract Sessions On-Demand Channel